| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.082 | 0.3 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |